Insurance Plays Significant Role in Breast Cancer Disparities

(ACS) Oct 16, 2017 - Differences in insurance account for a substantial proportion of the excess risk of death from breast cancer faced by black women, according to a new study.

read press release

Stand Up To Cancer Catalyst® Launches 10 Clinical Trial Projects Combining Cancer Treatments from Nine Different Pharmaceutical Companies to Explore Innovative Approaches and Find New Indications for Blockbuster Drugs to Improve Patient Outcomes

(AACR) Oct 12, 2017 - Stand Up To Cancer (SU2C) has awarded 10 SU2C Catalyst® clinical trial projects in which researchers from more than 30 institutions collaborate across academic and corporate borders on clinical trials – with correlated translational research which will deepen our understanding of why treatments are effective – across a variety of cancers, in a program supported by industry.

read press release

Immunotherapy Treatments For Cancer Gain Momentum

(Wall Street Journal) Oct 12, 2017 - In recent case, woman with metastatic breast cancer is cancer-free after infusion of immune cells at National Cancer Institute.

read article (paid subscription required)

Frozen Gloves, Socks Reduce CIPN in Patients With Breast Cancer

(Medscape Medical News) Oct 12, 2017 - Cryotherapy delivered to the hands and feet during weekly paclitaxel chemotherapy significantly reduces the incidence of peripheral neuropathy in patients with breast cancer.

read article (free registration required)

FDA Grants Priority Review for Potential New Indication for Lilly's Verzenio(TM) (abemaciclib) as Initial Treatment of Advanced Breast Cancer

(Lilly) Oct 12, 2017 - Eli Lilly and Company today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review designation for its New Drug Application (NDA) for Verzenio™ (abemaciclib), a cyclin-dependent kinase (CDK)4 & 6 inhibitor.

read corporate press release

U of T Startup Janpix Receives $22 Million In Funding To Advance Cancer Therapies

(U of T News) Oct 11, 2017 - STATs have been identified in numerous human cancers, including breast, blood and brain tumours. A University of Toronto researcher is developing ways to inhibit two STAT proteins, STAT3 and STAT5.

read press release

Surviving Breast Cancer: Reconstruction Surgery After Mastectomy More Popular Than Ever

(Newsweek) Oct 10, 2017 - The number of women who opt for breast reconstruction after mastectomy has skyrocketed 65 percent in five years.

read article

Seattle Genetics Announces Additional Clinical Collaborations to Evaluate SGN-LIV1A in Triple Negative Breast Cancer

(StreetInsider) Oct 11, 2017 - Seattle Genetics, Inc. today announced two clinical collaboration agreements for the evaluation of SGN-LIV1A in patients with triple negative breast cancer (TNBC).

read article

Merck KGaA Gives Back To Society Through Merck Foundation’s Program To Improve Access To Cancer Care

(CNBCAfrica/APO) Oct 9, 2017 - The Merck Foundation (, a subsidiary of Merck KGaA, Darmstadt, Germany. has started a very important Cancer Access program to provide Africa with New Oncologists through a one, two and three-year Oncology Fellowship Program established in India, Kenya and Egypt.

read article

Test for Breast Cancer Risk Could Reduce Pre-Emptive Mastectomies

(The Guardian [UK]) Oct 8, 2017 - Researchers develop gene test that will give more detailed information on risk to women with BRCA1 and BRCA2 mutations.

read article

Study Finds Double Mastectomy Tied To More Missed Work

(University of Michigan Health/M Health Lab) Oct 9, 2017 - Women who pursue a more aggressive surgery for early stage breast cancer have nearly eight times the odds of reporting substantial employment disruptions, according to a new study from University of Michigan Comprehensive Cancer Center researchers.

read article

Cleveland Clinic Researchers Find Link Between Bacterial Imbalances and Breast Cancer

(Cleveland Clinic) Oct 5, 2017 - In a newly published study, Cleveland Clinic researchers have uncovered differences in the bacterial composition of breast tissue of healthy women vs. women with breast cancer.

read press release

Mystery of Breast Cancer Risk Gene Solved, 20 Years After Its Discovery

(Yale News) Oct 4, 2017 - Yale scientists have pinpointed the molecular mechanism that allows mutations in the gene that predisposes women to breast cancer.

read article

Athenex Announces Positive Recommendations from the Drug Safety Monitoring Board to Continue the Oraxol Phase III Program

(Morningstar) Oct 5, 2017 - Athenex, Inc. today announced that a planned interim analysis of the Oraxol 001 Phase III Clinical Trial has been conducted and reviewed by an independent Drug Safety Monitoring Board (DSMB).

read article

Susan G. Komen® Launches Its First Crowdfunding Initiative To Support Metastatic Breast Cancer Research

(Susan G. Komen®) Oct 3, 2017 - Individuals and organizations looking to contribute to advancements in metastatic breast cancer research can now do so by participating in Susan G. Komen’s inaugural crowdfunding initiative, launched today in recognition of National Breast Cancer Awareness Month (NBCAM).

read press release

Trastuzumab Treatment for HER-2-Expressing Tumors Need Not Delay Breast Reconstruction Following Mastectomy

(American College of Surgeons) Oct 3, 2017 - Treatment with trastuzumab (Herceptin/Genentech) of breast cancers that express the HER-2 protein does not increase the risk for complications at the surgical site for women who undergo immediate breast reconstruction after mastectomy.

read press release

Genetic Targets To Chemo-Resistant Breast Cancer Identified

(UT Southwestern) Oct 3, 2017 - Research led by Dr. Carlos Arteaga, Director of the Harold C. Simmons Comprehensive Cancer Center, has identified potential targets for treatment of triple negative breast cancer, the most aggressive form of breast cancer.

read press release

Cancers Associated with Overweight and Obesity Make up 40 percent of Cancers Diagnosed in the United States

(CDC) Oct 3, 2017 - Overweight and obesity are associated with increased risk of 13 types of cancer. These cancers account for about 40 percent of all cancers diagnosed in the United States in 2014, according to the latest Vital Signs report by the Centers for Disease Control and Prevention (CDC).

read press release

Elekta and The Alliance for Cancer Care Partner to Bring Leading-edge Radiation Therapy and Radiosurgery Solutions to Patients

(Yahoo! Finance) Oct 2, 2017 - The Alliance for Cancer Care converts all oncology treatment devices and software to Elekta products, improving and standardizing care across its multiple sites.

read article

Breast-cancer Death Rate Drops Almost 40 Percent, Saving 322,000 Lives, Study Says

(Washington Post/To Your Health) Oct 3, 2017 - Breast cancer death rates declined almost 40 percent between 1989 and 2015, averting 322,600 deaths, the American Cancer Society reported Tuesday.

read article (free registration required)
Next Page